Journal Article

IV.3.2 Therapy conversion

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue suppl_4, pages 20-21
Published in print April 2002 | ISSN: 0931-0509
Published online April 2002 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/17.suppl_4.20
IV.3.2 Therapy conversion

Show Summary Details

Preview

Guideline

A. Conversion of immunosuppressive drug therapy is recommended to avoid or reduce drug‐specific adverse effects, and is generally safe for long‐term graft outcome.

(Evidence level A)

Journal Article.  0 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.